We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+51.28%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$2.14B
AUM Growth
+$558M
Cap. Flow
-$34.4M
Cap. Flow %
-1.61%
Top 10 Hldgs %
89.61%
Holding
40
New
–
Increased
–
Reduced
1
Closed
4

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$26.2M
2
DM
Desktop Metal, Inc.
DM
+$5.42M
3
KRON
Kronos Bio
KRON
+$1.19M
4
VERV
Verve Therapeutics
VERV
+$1.03M
5
RANI icon
Rani Therapeutics
RANI
+$565K

Sector Composition

Rank Sector Weight
1 Technology 55.72%
2 Healthcare 35.16%
3 Industrials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRX icon
26
TScan Therapeutics
TCRX
$51.9M
$1.56M 0.07%
1,077,080
– –
TSHA icon
27
Taysha Gene Therapies
TSHA
$1.59B
$1.48M 0.07%
640,882
– –
BRNS
28
Barinthus Biotherapeutics
BRNS
$24.6M
$1.41M 0.07%
1,513,644
– –
EXAS
29
DELISTED
Exact Sciences
EXAS
$1.23M 0.06%
23,205
– –
GUTS icon
30
Fractyl Health
GUTS
$123M
$1.07M 0.05%
662,584
– –
HYPR icon
31
Hyperfine
HYPR
$94.7M
$647K 0.03%
898,720
– –
TNYA icon
32
Tenaya Therapeutics
TNYA
$168M
$559K 0.03%
915,705
– –
QNCX icon
33
Quince Therapeutics
QNCX
$17.5M
$312K 0.01%
946
– –
ALEC icon
34
Alector
ALEC
$164M
$246K 0.01%
175,866
– –
FULC icon
35
Fulcrum Therapeutics
FULC
$248M
$98.1K ﹤0.01%
14,262
– –
RGEN icon
36
Repligen
RGEN
$7.44B
$47.6K ﹤0.01%
383
– –
CRWD icon
37
CrowdStrike
CRWD
$187B
– –
-296,920
Closed -$26.2M
KRON
38
DELISTED
Kronos Bio
KRON
– –
-1,438,232
Closed -$1.19M
RANI icon
39
Rani Therapeutics
RANI
$95.6M
– –
-448,492
Closed -$565K
DM
40
DELISTED
Desktop Metal, Inc.
DM
– –
-1,104,871
Closed -$5.42M
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q2 2025 Portfolio in Review

As of Q2 2025, Alphabet Inc held 40 positions worth $2.14B, up 35% from $1.58B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Alphabet Inc's Q2 2025 filing shows 1 reduced and 4 closed positions. The largest sale was CrowdStrike, an estimated $26.2M.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 55% a quarter earlier, followed by Healthcare and Industrials.

  • Alphabet Inc's biggest Q2 2025 reduction was Verve Therapeutics, cutting an estimated $1.03M.
  • Alphabet Inc fully exited CrowdStrike in Q2 2025, selling an estimated $26.2M.
  • Alphabet Inc's ten largest holdings make up 90% of its $2.14B portfolio in Q2 2025.
  • Alphabet Inc opened 0 new positions and closed 4 in Q2 2025.
  • Alphabet Inc's portfolio value rose 35% quarter-over-quarter to $2.14B.

Based on Alphabet Inc's 13F filing for Q2 2025, filed 1 Aug 2025.